News
Appropriate use criteria for imaging in nonvalvular heart disease released
January 7, 2019
The document systematically reviews scenarios intended to reflect real-life situations.
![1]()
News
New diabetes drugs solidify their cardiovascular and renal benefits
January 7, 2019
CHICAGO – Empagliflozin’s heart failure and renal benefits surprised when reported in 2015. The evidence has grown stronger and broader since.
![1]()
News
Hospital Readmissions Reduction Program may be doing more harm than good
January 4, 2019
Thirty-day postdischarge mortality went up after the program for some, down for others.
![1]()
News
Can higher MAP post cardiac arrest improve neurologic outcomes?
December 21, 2018
CHICAGO – A target mean arterial pressure higher than what the guidelines recommend appears safe but has mixed results for improving neurologic outcomes.
![1]()
News
Digital alerts reduced AF-related stroke, MI rates
December 18, 2018
CHICAGO – A computerized decision support system increased anticoagulation rates and reduced cardiac event rates in at-risk atrial fibrillation patients.
News
AHA: Statins associated with high degree of safety
December 10, 2018
Rumors of statins’ adverse side effects are greatly exaggerated.
![1]()
News
Phone app diagnoses STEMI nearly as well as ECG
December 7, 2018
CHICAGO – With some tweaking, the AliveCor app could improve outcomes by speeding up diagnosis and treatment.
![1]()
News
Acute stroke thrombolysis worked safely despite GI bleed or malignancy
December 7, 2018
CHICAGO – Current guidelines contraindicate acute stroke thrombolysis in patients with GI bleed or malignancy, but a new analysis suggests it’s safe.
![1]()
News
EARLY: Angiography within 2 hours of acute non-ST event cut recurrent ischemic events
December 4, 2018
Coronary angiography immediately after an acute non–ST-segment elevation coronary event limited recurrent events, compared with later intervention.
![1]()
Video
ARISTOPHANES: Apixaban edges other DOACS for octogenarians
December 2, 2018
CHICAGO – Insurance claims data from more than 50,000 U.S. octogenarians on a DOAC showed apixaban worked best and caused the fewest major bleeds.
